All News

Breast cancer survivor and Evofem Biosciences founder and CEO Saundra Pelletier shares her thoughts on a new hormone-free contraceptive gel that could improve sexual quality of life in patients with cancer.

A cancer survivor offers some statistics about the longevity of cancer survivors.

As part of its Speaking Out video series, CURE® spoke with Dr. Steven M. Horwitz on behalf of the Cutaneous Lymphoma Foundation about cutaneous T-cell lymphoma and options for treatment.

There are several health equity barriers in patients with cancer, one of which involves adequate access to clinical trials. Here, a panel of experts and a cancer survivor discuss ways to improve access.

Oncologists and researchers are racing to identify new therapies to help better treat a rare form of acute lymphoblastic leukemia.

Cancer survivors are just like snowflakes in that they are unique and not the same, says a two-time cancer survivor.

From the death of Bill Ludwig, the first patient to receive CAR-T cell therapy to treat his end-stage CLL, to a letter to the President urging him to grant patients with cancer and survivors priority access to the COVID-19 vaccine, here’s what’s happening in the cancer space this week.

The past year has spotlighted racial inequities not only in the U.S., but worldwide. It has also opened our eyes as to how a major health disruption — in this case, a pandemic — can aggravate the unacceptable status quo.

The Society of Breast Imaging has recommended women wait four to six weeks after receiving their second dose of a COVID-19 vaccine to get a screening mammogram. However, experts differ on whether women should wait to get a screening mammogram following their vaccine.

Former longtime Kansas senator Bob Dole announced that he will be undergoing treatment for lung cancer next week.

This week on the “CURE® Talks Cancer” podcast, we spoke with Evofem Biosciences founder and CEO Saundra Pelletier about what it was like to go through the shock of receiving a cancer diagnosis while also navigating a career, and explaining how her product, which is now FDA-approved, can help patients with cancer and survivors improve their sexual quality of life.

The study results, according to one expert, show that Cabometyx should be considered the new standard for systemic therapy in patients with metastatic papillary renal cell carcinoma.

Local access to national cancer studies allows patients to receive promising new treatments in the most convenient setting possible: Their own community.

Conservative radio host Rush Limbaugh, 70, has died after receiving an advanced lung cancer diagnosis one year ago.

A caregiver recalls how an unexpected side effect of her daughter’s breast cancer treatment has caused her to experience feelings of helpless anger.

Although physical effects of cancer may be well known, people often overlook the emotional responses that patients with cancer experience.

A meta-analysis found that minimal residual disease positivity after a particular treatment for mantle cell lymphoma can predict worse survival benefit.

Although many cancers are unseen, different types of treatment can lead to painful, visible side effects, particularly when it comes to an individual's skin.

A physical therapist recalls how one of her patient’s with prostate cancer hated exercise when he first came to visit her, but then his mindset changed once he realized his lymphedema started to get under control.

Black and Latino patients are more likely to receive a diagnosis of and die of cancer than White patients. How can we end this disparity?

Patents with HER2-positive breast cancer had a similar rate of overall survival with Perjeta plus chemotherapy and trastuzumab compared with placebo plus chemotherapy and trastuzumab, although longer follow-up is needed to determine whether a benefit exists in that area.

On social media, CURE® recently asked its readers to share their thoughts on getting the HPV vaccine to help prevent certain types of cancer later in life. Here is what some of them shared.

To honor National Cancer Prevention Month in February, one patient with cancer offers people some tips on how they certain medical and societal choices may help reduce the risk of cancer.

The NCCN has updated its recommendations for chronic lymphocytic leukemia and small lymphocytic lymphoma to now include Brukinsa as a first- and second-line therapy in a subgroup of patients.

One patient with breast implant-associated anaplastic large cell lymphoma spoke out for herself throughout therapy — and encourages other patients do the same.

A cancer survivor remembers his wife who died of complications from ovarian cancer on Valentine’s Day several years ago. His advice to everyone: Holidays gradually become positive reflections of all that was good before cancer took it away.

The results of the phase 3 trial, according to one expert, support the use of Lenvima with Keytruda as a possible first-line treatment option for patients with advanced renal cell carcinoma.

Treatment with sapanisertib was associated with limited activity and poor safety outcomes in patients with refractory metastatic renal cell carcinoma.